시장보고서
상품코드
1593482

세계의 파이로젠 시험 - 시장 규모, 점유율, 성장 분석 : 제품별, 테스트 유형별, 최종 사용자별, 지역별 산업 예측(2024-2031년)

Pyrogen Testing Market Size, Share, Growth Analysis, By Product, By Test Type, By End-Use, By Region - Industry Forecast 2024-2031.

발행일: | 리서치사: SkyQuest | 페이지 정보: 영문 176 Pages | 배송안내 : 3-5일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

파이로젠 시험 세계 시장 규모는 2022년에 13억 2,230만 달러로 평가되었고, 2023년 14억 9,948만 달러에서 2031년에는 41억 59만 달러로 성장해 예측 기간(2024-2031년)의 CAGR은 13.4%에 달할 전망입니다.

파이로젠 시험 시장은 발열의 원인이 되는 발열물질을 제거함으로써 의료기기나 의약품기기의 안전성을 확보하는데 필수적입니다. 생물 제제의 생산량 증가에 힘입어 시장은 급속히 발전하고 있습니다. 주된 요인으로는 시험기술의 진보에 더해 품질관리 및 국제규격에의 준거의 강화를 들 수 있습니다. 이러한 장애에도 불구하고 시험 프로세스의 디지털 화와 자동화, 생물 제제 및 바이오 의약품 분야의 확대로 시장은 향후 수년간 대폭적인 성장이 예상되고 있습니다. 중요성이 인식되고 있음을 보여 주며 건강 관리 생태계의 파이 로젠 시험의 역할을 확고하게 하고 있습니다. 제조업체가 품질 보증 대책을 강화해 복잡한 규제를 극복하고 있는 동안, 파이로젠 시험 시장은 환자 케어의 계속적인 동향과 현대의 의료 행위에 있어서의 컴플라이언스입니다.

목차

소개

  • 조사의 목적
  • 조사 범위
  • 정의

조사 방법

  • 정보 조달
  • 2차 데이터와 1차 데이터의 방법
  • 시장 규모 예측
  • 시장의 상정과 제한

주요 요약

  • 세계 시장 전망
  • 공급과 수요의 트렌드 분석
  • 부문별 기회 분석

시장 역학과 전망

  • 시장 개요
  • 시장 규모
  • 시장 역학
    • 성장 촉진요인과 기회
    • 억제요인과 과제
  • Porter's Five Forces 분석과 영향
    • 경쟁 기업간 경쟁 관계
    • 대체품의 위협
    • 구매자의 협상력
    • 신규 진입업자의 위협
    • 공급기업의 협상력

주요 시장 인사이트

  • 중요성공요인
  • 경쟁도
  • 주요 투자 기회
  • 시장 생태계
  • 기술의 진보
  • 규제 상황
  • 특허 분석
  • 밸류체인 분석
  • 사례 연구 분석
  • PESTEL 분석
  • 거시경제지표
  • 무역 분석
  • 스타트업 분석
  • 시장의 매력 지수
  • 가격 분석

파이로젠 시험 시장 규모 : 제품 및 서비스별 CAGR(2024-2031년)

  • 분석 키트 시약
  • 기기
  • 서비스

파이로젠 시험 시장 규모 : 테스트 유형별 CAGR(2024-2031년)

  • LAL 테스트
    • 발색성 시험
    • 탁도 측정 시험
    • 겔 응고 시험
  • 체외시험
  • 토끼 테스트

파이로젠 시험 시장 규모 : 최종사용자별 CAGR(2024-2031년)

  • 제약·바이오테크놀러지 기업
  • 의료기기 기업
  • 기타 최종 사용자

파이로젠 시험 시장 규모 : CAGR(2024-2031년)

  • 북미(제품 및 서비스, 테스트 유형, 최종 사용자)
    • 미국
    • 캐나다
  • 유럽(제품 및 서비스, 테스트 유형, 최종 사용자)
    • 영국
    • 독일
    • 스페인
    • 프랑스
    • 이탈리아
    • 기타 유럽
  • 아시아태평양(제품 및 서비스, 테스트 유형, 최종 사용자)
    • 중국
    • 인도
    • 일본
    • 한국
    • 기타 아시아태평양
  • 라틴아메리카(제품 및 서비스, 테스트 유형, 최종 사용자)
    • 브라질
    • 기타 라틴아메리카
  • 중동 및 아프리카(제품 및 서비스, 테스트 유형, 최종 사용자)
    • GCC 국가
    • 남아프리카
    • 기타 중동 및 아프리카

경쟁 정보

  • 상위 5개사 비교
  • 주요 기업의 시장 포지셔닝(2023년)
  • 주요 시장 기업이 채용한 전략
  • 시장의 최근 동향
  • 기업의 시장 점유율 분석(2023년)
  • 주요 기업의 기업 프로파일
    • 기업 개요
    • 제품 포트폴리오 분석
    • 부문별 점유율 분석
    • 수익의 전년대비 비교(2021-2023년)

주요 기업 프로파일

  • Merck KGaA
  • GenScript
  • Hyglos GmbH
  • Ellab A/S
  • Lonza
  • Thermo Fisher Scientific, Inc.
  • Charles River Laboratories, Inc.
  • Associates of Cape Cod, Inc.
  • Pyrostar
  • Abbott Laboratories
  • AstraZeneca
  • Heraeus Medical
  • Wako Pure Chemical Industries
  • Roche Diagnostics
  • Biosafe Technologies
  • BIOMERIEUX SA
  • GENSCRIPT BIOTECH CORPORATION
  • EUROFINS SCIENTIFIC
  • WUXI APPTEC
  • STERIS PLC

결론과 권장사항

JHS 24.11.29

Global Pyrogen Testing Market size was valued at USD 1322.30 Million in 2022 and is poised to grow from USD 1499.48 Million in 2023 to USD 4100.59 Million by 2031, growing at a CAGR of 13.4% in the forecast period (2024-2031).

The pyrogen testing market is vital for ensuring the safety of medical and pharmaceutical devices by eliminating pyrogens, which can cause fever. Driven by heightened patient safety awareness, stringent regulatory requirements, and the increasing production of pharmaceuticals and biologics, the market is evolving rapidly. Key factors fueling its growth include a stronger emphasis on quality control and compliance with international standards, alongside advancements in testing technologies. However, challenges such as the dynamic regulatory landscape and low awareness regarding pyrogen testing are hindering broader adoption. Despite these obstacles, the market is anticipated to experience substantial growth in the coming years, largely propelled by the digitalization and automation of testing processes, as well as the expansion of the biologics and biopharmaceutical sectors. This upward trajectory indicates a growing recognition of the importance of pyrogen testing in ensuring product safety and efficacy, solidifying its role in the healthcare ecosystem. As manufacturers continue to enhance their quality assurance measures and navigate regulatory complexities, the pyrogen testing market is poised to thrive, reflecting ongoing trends in patient care and the increasingly critical nature of compliance in modern medical practices.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Pyrogen Testing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Pyrogen Testing Market Segmental Analysis

Global Pyrogen Testing Market is segmented by Product & Service, Test Type, end user and region. Based on Product & Service, the market is segmented into Assays, Kits, & Reagents, Instruments, Services. Based on Test Type, the market is segmented into LAL Tests, Chromogenic Tests, Turbidimetric Tests, Gel Clot Tests,In Vitro Tests, Rabbit Tests. Based on end user, the market is segmented into Pharmaceutical & Biotechnology Companies, Medical Device Companies, Other End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the Global Pyrogen Testing Market

The burgeoning development of novel drug classes, advanced therapies, and biologics-such as gene therapies, monoclonal antibodies, and cell therapies-has emerged as a significant market driver for the Global Pyrogen Testing market. As these complex products necessitate stringent testing protocols to ensure their efficacy and safety, there is a critical demand for highly efficient and reliable pyrogen testing processes. Additionally, escalating research and development activities within the biotechnology and pharmaceutical sectors are amplifying the need for pyrogen testing services, particularly given the increasing volume of medical devices and therapeutic applications being brought to market. This convergence of innovation and regulatory demands creates a fertile environment for the growth of pyrogen testing solutions worldwide.

Restraints in the Global Pyrogen Testing Market

The Global Pyrogen Testing market faces significant restraints due to the specialized skills and knowledge required for effective testing. The complexity of the testing processes-ranging from sample preparation to result interpretation-demands highly trained professionals, creating a barrier for some facilities that may lack the necessary expertise. Furthermore, the inherently time-consuming nature of pyrogen testing, which involves multiple stages, can lead to delays in product development and regulatory approval processes. These factors collectively hinder operational efficiency and may deter investment in pyrogen testing capabilities, ultimately limiting the market's potential for growth and innovation.

Market Trends of the Global Pyrogen Testing Market

The Global Pyrogen Testing market is experiencing a significant trend towards high-throughput screening and automation, revolutionizing the testing landscape. By integrating advanced automation systems, companies can efficiently handle large volumes of samples, enhancing both accuracy and consistency while simultaneously reducing operational costs and minimizing human errors. This shift towards automated solutions facilitates rapid and comprehensive testing, catering to the growing demand within the pharmaceutical and biotechnology sectors for swift and reliable pyrogen detection. As regulatory requirements tighten and the need for streamlined workflows increases, the pyrogen testing market is poised for robust growth, driven by technological advancements that optimize testing processes.

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Driver & Opportunities
    • Restraints & Challenges
  • Porters Analysis & Impact
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Technological Advancement
  • Regulatory Landscape
  • Patent Analysis
  • Value Chain Analysis
  • Case Study Analysis
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Trade Analysis
  • Startup Analysis
  • Market Attractiveness Index
  • Pricing Analysis

Global Pyrogen Testing Market Size by Product & Service & CAGR (2024-2031)

  • Assays, Kits, & Reagents
  • Instruments
  • Services

Global Pyrogen Testing Market Size by Test Type & CAGR (2024-2031)

  • LAL Tests
    • Chromogenic Tests
    • Turbidimetric Tests
    • Gel Clot Tests
  • In Vitro Tests
  • Rabbit Tests

Global Pyrogen Testing Market Size by End User & CAGR (2024-2031)

  • Pharmaceutical & Biotechnology Companies
  • Medical Device Companies
  • Other End Users

Global Pyrogen Testing Market Size & CAGR (2024-2031)

  • North America, (Product & Service, Test Type, End User)
    • US
    • Canada
  • Europe, (Product & Service, Test Type, End User)
    • UK
    • Germany
    • Spain
    • France
    • Italy
    • Rest of Europe
  • Asia-Pacific, (Product & Service, Test Type, End User)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia Pacific
  • Latin America, (Product & Service, Test Type, End User)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa, (Product & Service, Test Type, End User) )
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2023
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2023
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

  • Merck KGaA
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • GenScript
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Hyglos GmbH
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Ellab A/S
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Lonza
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Thermo Fisher Scientific, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Charles River Laboratories, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Associates of Cape Cod, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Pyrostar
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Abbott Laboratories
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • AstraZeneca
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Heraeus Medical
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Wako Pure Chemical Industries
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Roche Diagnostics
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Biosafe Technologies
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • BIOMERIEUX SA
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • GENSCRIPT BIOTECH CORPORATION
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • EUROFINS SCIENTIFIC
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • WUXI APPTEC
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • STERIS PLC
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendation

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제